Your browser version may not work well with NCBI's Web applications. More information here...
1: Gastroenterology. 1990 Aug;99(2):533-5.Links

Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.

Hayashi H, Higuchi T, Ichimiya H, Hishida N, Sakamoto N.

Third Department of Medicine, Nagoya University School of Medicine, Japan.

Ursodeoxycholic acid treatment (600 mg/day) was evaluated in a patient with asymptomatic primary sclerosing cholangitis. Serum levels of biliary enzymes decreased to normal ranges within 1 month's treatment and remained normal for 26 months. Serum chenodeoxycholic acid had been replaced by ursodeoxycholic acid, and hepatic copper metabolism, assessed by x-ray probe analysis, improved during the treatment. However, neither biliary tract sclerosis nor portal tract pathology changed with the treatment. These observations suggest that ursodeoxycholic acid protects the liver in primary sclerosing cholangitis by improving the metabolism of bile acid and copper.

PMID: 2365199 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Ursodiol (Actigall® )

    Ursodiol is used to dissolve gallstones in patients who do not want surgery or cannot have surgery to remove gallstones. Ursodiol is also used to prevent the formation of gallstones in overweight patients who are losing ...

  • Source: AHFS Consumer Medication Information